EUVIMED · CrossrefJournal
Vaccine: Development and Therapy
ISSN 2230-2298 · Informa UK Limited
Latest articles
Management of visceral leishmaniasis with therapeutic vaccines
A new forum to spread the word on vaccine research
Recombinant Rhipicephalus appendiculatus gut (Ra86) and salivary gland cement (Trp64) proteins as candidate antigens for inclusion in tick vaccines: protective effects of Ra86 on infestation with adult R. appendiculatus
Advances in the development of vaccines for dengue fever
The utility of human challenge studies in vaccine development: lessons learned from cholera
New recombinant vaccines for the prevention of meningococcal B disease
Current research and clinical trials for a vaccine against Chikungunya virus
Realizing the promise of breast cancer vaccines
Melanoma vaccines: trials and tribulations
Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development
Reasons for not having received influenza vaccination and its predictors in Canadians
Assessment of chicken protection against Campylobacter jejuni infection by immunization with avirulent Salmonella enterica sv. Typhimurium strain producing Campylobacter CjaD/Pal protein
Review of recent literature on microneedle vaccine delivery technologies
Key feasibility considerations when conducting vaccine clinical trials in Asia–Pacific countries
Forced degradation studies: an essential tool for the formulation development of vaccines
Challenges to developing effective streptococcal vaccines to prevent rheumatic fever and rheumatic heart disease
Vaccines for metabolic diseases: current perspectives
Current and future prophylactic vaccines for hepatitis C virus
Immunogenicity and safety of live attenuated hepatitis A vaccine (Biovac-A™) in healthy Indian children
RTS,S malaria vaccine development: progress and considerations for postapproval introduction
Changing epidemiology of hepatitis A virus in Indian children
Pertussis vaccine in pregnant women: safety and uptake
Evaluating the safety and immunogenicity of yellow fever vaccines: a systematic review
Immunization and chemical conjugation of Bm95 obtained from Pichia pastoris enhances the immune response against vaccinal protein and Neisseria meningitidis capsular polysaccharide
Current progress toward vaccines against Toxoplasma gondii
Immunosenescence: implications for vaccination programs in the elderly
Development of a vaccine for Chlamydia trachomatis: challenges and current progress
A database in ACCESS for assessing vaccine serious adverse events
Tularemia vaccine development: paralysis or progress?
Hendra and Nipah viruses: pathogenesis, animal models and recent breakthroughs in vaccination
EUVIMED